MURPHY BARTON: Open Payments
NPI 1306543665 · PINEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,405 in 78 payments from 11 companies in 2025. Trend: 2023 $285 · 2024 $1,225 · 2025 $1,405
Food & beverage: $1,405
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $672 |
| Axsome Therapeutics, Inc. | 16 | $369 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| Ardelyx, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Insulet Corporation | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
Products named: QULIPTA, Auvelity, VRAYLAR, UBRELVY, CAPLYTA, REXULTI, IBSRELA, JARDIANCE.
Industry payments across LA — which companies pay providers there.
